User profiles for Simon Walsh

Simon Walsh

National Heart and Lung Institute, Imperial College, London
Verified email at imperial.ac.uk
Cited by 14132

Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline

…, M Selman, WD Travis, SLF Walsh… - American journal of …, 2018 - atsjournals.org
Background: This document provides clinical recommendations for the diagnosis of
idiopathic pulmonary fibrosis (IPF). It represents a collaborative effort between the American …

[HTML][HTML] Nintedanib in progressive fibrosing interstitial lung diseases

…, V Cottin, A Devaraj, SLF Walsh… - … England Journal of …, 2019 - Mass Medical Soc
Background Preclinical data have suggested that nintedanib, an intracellular inhibitor of
tyrosine kinases, inhibits processes involved in the progression of lung fibrosis. Although the …

Diagnosis of hypersensitivity pneumonitis in adults: an official ATS/JRS/ALAT clinical practice guideline

…, ML Salisbury, M Selman, SLF Walsh… - American journal of …, 2020 - atsjournals.org
Background: This guideline addresses the diagnosis of hypersensitivity pneumonitis (HP). It
represents a collaborative effort among the American Thoracic Society, Japanese …

Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open …

…, JF Lassen, M Maeng, K Oldroyd, G Berg, SJ Walsh… - The Lancet, 2016 - thelancet.com
Background Coronary artery bypass grafting (CABG) is the standard treatment for revascularisation
in patients with left main coronary artery disease, but use of percutaneous coronary …

Forensic implications of genetic analyses from degraded DNA—a review

R Alaeddini, SJ Walsh, A Abbas - Forensic science international: genetics, 2010 - Elsevier
Forensic DNA identification techniques are principally based on determination of the size or
sequence of desired PCR products. The fragmentation of DNA templates or the structural …

[HTML][HTML] Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study

SLF Walsh, AU Wells, SR Desai, V Poletti… - The lancet Respiratory …, 2016 - thelancet.com
Background Diffuse parenchymal lung disease represents a diverse and challenging group
of pulmonary disorders. A consistent diagnostic approach to diffuse parenchymal lung …

Hypersensitivity pneumonitis: perspectives in diagnosis and management

M Vasakova, F Morell, S Walsh, K Leslie… - American journal of …, 2017 - atsjournals.org
Awareness of hypersensitivity pneumonitis (HP) as a unique disease entity dates back to the
18th century (1). Since then, numerous inciting agents have been attributed to inducing HP, …

Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the …

…, JF Lassen, K Oldroyd, G Berg, P Stradins, SJ Walsh… - The Lancet, 2020 - thelancet.com
Background Percutaneous coronary intervention (PCI) is increasingly used in revascularisation
of patients with left main coronary artery disease in place of the standard treatment, …

Quadriceps wasting and physical inactivity in patients with COPD

…, ZA Puthucheary, SLF Walsh… - European …, 2012 - Eur Respiratory Soc
Quadriceps weakness is an important complication of advanced chronic obstructive
pulmonary disease (COPD) but few data exist concerning muscle bulk in early disease. We …

Transbronchial cryobiopsies for the diagnosis of diffuse parenchymal lung diseases: expert statement from the cryobiopsy working group on safety and utility and a …

…, N Sverzellati, D Valeyre, D Leduc, SLF Walsh… - Respiration, 2018 - karger.com
Transbronchial cryobiopsies (TBCB) have recently been introduced as a promising and safer
alternative to surgical lung biopsy in the diagnostic approach to diffuse parenchymal lung …